✦ LIBER ✦

Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer

✍ Scribed by Teppei Morikawa; Daichi Maeda; Haruki Kume; Yukio Homma; Masashi Fukayama

Book ID: 108780990
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 900 KB
Volume: 57
Category: Article
ISSN: 0309-0167
DOI: 10.1111/j.1365-2559.2010.03725.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TGM2Is a Novel Marker for Prognosis and

TGM2Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer

✍ Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Toshiki Hitora; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 299 KB

CD147 overexpression is a prognostic fac

CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer

✍ Yi-Jun Xue; Qiang Lu; Zhi-Xi Sun 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 465 KB

TGFβR2 aberrant methylation is a potenti

TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma

✍ Fabrício de Carvalho; Gisele W. B. Colleoni; Manuella S. Sampaio Almeida; André 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

## Abstract Multiple myeloma (MM) is an incurable hematological malignancy. Different studies demonstrated the occurrence of genetic and epigenetic alterations in MM. The aberrant methylation is one of the most frequent epigenetic alterations in human genome. This study evaluated the aberrant methy

Focal adhesion kinase serves as a marker

Focal adhesion kinase serves as a marker of cervical lymph node metastasis and is a potential therapeutic target in tongue cancer

✍ Hongbing Jiang; Laikui Liu; Jinhai Ye; Hualian Liu; Shuzhong Xing; Yunong Wu 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 722 KB